Veeva Systems (VEEV) announced a collaboration with Amgen (AMGN) to advance clinical trial innovation. Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process. As part of the collaboration, Veeva Business Consulting will support Amgen through implementation and change management.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Veeva price target raised to $349 from $329 at Citi
- Veeva price target raised to $300 from $270 at Canaccord
- Veeva Systems: Strong Financial Performance and Strategic Positioning Drive Buy Rating
- Veeva price target raised to $355 from $325 at Piper Sandler
- Veeva price target raised to $341 from $326 at Wells Fargo